| Q43561057 | A reverse microemulsion polymerization method for preparation of bioadhesive polyacrylic acid nanoparticles for mucosal drug delivery: loading and release of timolol maleate |
| Q77758387 | An in vitro model for investigating the gastric mucosal retention of 14C-labelled poly(acrylic acid) dispersions |
| Q35501031 | Bioactivity of WLBU2 peptide antibiotic in combination with bioerodible polymer |
| Q35097725 | Bioadhesive microspheres as a controlled drug delivery system. |
| Q46595820 | Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation |
| Q78139074 | Carbomer inhibits tryptic proteolysis of luteinizing hormone-releasing hormone and N-alpha-benzoyl-L-arginine ethyl ester by binding the enzyme |
| Q74604472 | Carboxyethylester-polyrotaxanes as a new calcium chelating polymer: synthesis, calcium binding and mechanism of trypsin inhibition |
| Q53775903 | Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. |
| Q44258528 | Covalent coupling of concanavalin A to a Carbopol 934P and 941P carrier in glucose-sensitive gels for delivery of insulin |
| Q43569889 | Development and characterization of a novel peroral peptide drug delivery system |
| Q35743547 | Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers |
| Q43989495 | Evaluation of the inhibition effect of thiolated poly(acrylates) on vaginal membrane bound aminopeptidase N and release of the model drug LH-RH. |
| Q41138055 | From sticky stuff to sweet receptors--achievements, limits and novel approaches to bioadhesion |
| Q30628888 | In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery |
| Q50449781 | In vitro evaluation of polyethylene glycol based microparticles containing azithromycin |
| Q44618073 | In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers |
| Q78018827 | Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement |
| Q73847818 | Interactions among proteins and hydrophobically modified polyelectrolytes |
| Q57343262 | Intranasal Clobazam Delivery in the Treatment of Status Epilepticus |
| Q40896415 | Lectin-mediated drug delivery: the second generation of bioadhesives |
| Q47265176 | Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight |
| Q41014361 | Molecular glues for manipulating enzymes: trypsin inhibition by benzamidine-conjugated molecular glues |
| Q36680101 | Molecular optical imaging of therapeutic targets of cancer |
| Q71862547 | Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo |
| Q73558351 | Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N |
| Q93930120 | Peroral administration of enzymes: strategies to improve the galenic of dosage forms for trypsin and bromelain |
| Q44010341 | Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin |
| Q40739233 | Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres for oral delivery of proteins |
| Q42172174 | Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery? |
| Q33983406 | Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review |
| Q44645341 | Preparation and in vitro characterization of poly(acrylic acid)–cysteine microparticles |
| Q92920551 | Self-assembled insulin and nanogels polyelectrolyte complex (Ins/NGs-PEC) for oral insulin delivery: characterization, lyophilization and in-vivo evaluation |
| Q49147648 | Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine |
| Q57345768 | Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan–mucin interactions |
| Q47758773 | The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins |
| Q33918818 | Transmucosal delivery systems for calcitonin: a review |